Market: NMS |
Currency: USD
Address: 10 Hanechoshet
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
Show more
📈 N/A Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for N/A
| Date | Reported EPS |
|---|
| 2024-04-22 | - |
📰 Related News & Research
-
Prospera Global Limited FY2025 Audited Financials: Going Concern Uncertainty, Regulatory Investigation Update & Dividend Information
April 6, 2026
Prospera Global Limited: FY2025 Financial Analysis and Outlo...
-
UpHealth Group Limited Announces Non-Issuance of FY2025 Sustainability Report Due to Cash Company Status and Plans for FY2026 Reporting 1
April 6, 2026
UpHealth Group Limited: Non-Issuance of FY2025 Sustainabilit...
-
Nam Cheong Secures Up to RM102.5 Million in Long-Term OSV Charters, Boosting Fleet Utilisation and Earnings Stability 1
April 6, 2026
Nam Cheong Secures OSV Charters Worth Up to RM102.5 Million ...
-
The Honest Company, Inc. Amends Credit Agreement: Key Terms, Definitions, and Executive Signatures Explained
April 6, 2026
The Honest Company, Inc. Enters Into First Amendment to Cred...
-
Global Superfoods Corp. 2025 Financial Statements and Audit Report Overview
April 6, 2026
Global Superfoods Corp. Files Form 8-K/A: Details of Navitas...
-
AirSculpt Technologies Reports 2025 Financial Results, Projects Revenue Growth and Improved EBITDA for 2026
April 6, 2026
AirSculpt Technologies Reports Q4 and Full Year 2025 Results...
-
Playtika Announces Strategic Alternatives Review to Maximize Shareholder Value (April 2026)
April 6, 2026
Playtika Announces Strategic Review Process to Maximize Shar...
-
Cycurion Reports 2025 Financial Results: Cost Reductions, AI Investments, and $112M Contract Backlog Position Company for 2026 Growth
April 6, 2026
Cycurion, Inc. 2025 Full-Year Financial Results – Investor-F...
-
Inflection Point Acquisition Corp. VI Audited Balance Sheet and Financial Statement for March 30, 2026
April 6, 2026
Summary of the Audited Financial Statement Inflection Poi...
-
Oxbridge Re Holdings Limited 2025 Executive Compensation, Board Governance, and Shareholder Information (10-K/A Highlights)
April 6, 2026
Oxbridge Re Holdings Ltd. Files 10-K/A: Key Shareholder and ...
🔍 View more Reports